ONLINE DISCUSSIONS
Learn best practices from experienced clinic operators on the opportunities and challenges running ketamine clinics and how to plan for the future of MDMA.
Kim Turpin
Co-Founder
PEARL PSYCHEDELIC INSTITUTE
Nykol Rice
Founder
BOISE KETAMINE CLINIC
Chris Walden
Co-Founder & CEO
KETAMINE MEDIA
Listen to industry professionals discuss and debate the opportunities and challenges of business in two very different legislative climates.
Sean McAllister
Attorney
MCALLISTER LAW OFFICE
Sheva Pekar
Founder
PSYCANN ADVISORS
Perry Salzhauer
Co-Founder
GREEN LIGHT LAW GROUP
! SAVE THE DATE !
! SAVE THE DATE !
Areas of interest for CAPSJ include:
– analytical testing
– botanical drug development
– clinical research
– pharmacology
– product manufacture
– psychedelic-assisted therapy
CAPSJ is looking for experts in psychedelics to join our editorial board, as well as our team of peer reviewers. For more info, contact us at [email protected]
We deliver a deep-dive analysis of the public’s perception of psychedelics — and how it has evolved over the last 50 years among the general population and healthcare community. A compilation of data spanning surveys, historical literature and recent studies.
This report will help you understand the major developments, opportunities and risks in the marketplace, including a deep dive into the competitive landscape and on-label vs off-label ketamine use.
Understanding the emerging state-regulated markets including: legislation, licenses, start-up costs and other considerations. Also, comparing psychedelic and cannabis legalization.
